Charanjeet Singh

Florida Hospital Cancer Institute, AdventHealth Orlando

Papers

2

Total Citations

54

H-Index

2

About

Dr. Charanjeet Singh is a leading gynecologic oncologist whose research focuses on refining sentinel lymph node (SLN) mapping in endometrial cancer. Her work has fundamentally advanced the understanding of how primary tumor histology and SLN metastasis size correlate with non-sentinel node involvement, directly informing surgical decision-making and reducing unnecessary lymphadenectomies. Her landmark 2019 study (37 citations) established critical thresholds for predicting metastatic spread, while her subsequent investigation into SLN mapping symmetry and failure patterns (17 citations) provided actionable insights for improving procedural accuracy. Through these contributions, Dr. Singh has helped standardize minimally invasive robotic SLN mapping protocols, enhancing both diagnostic precision and patient outcomes. Her research is widely cited in international guidelines, demonstrating its clinical impact. By bridging histopathologic findings with surgical technique, Dr. Singh continues to shape the paradigm of personalized, less invasive staging for endometrial cancer patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
54
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis
37 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Florida Hospital Cancer Institute, AdventHealth Orlando

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago